Source: FirstWord Pharma

H-CYTE: H-CYTE Announces Proceeds of $1.05 Million from Warrant Exercise

TAMPA, Fla., March 04, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, announced today that it has received $1,053,605 from the exercise of 75,257,511 previously is...

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Michael Yurkowsky's photo - CEO of H-CYTE

CEO

Michael Yurkowsky

CEO Approval Rating

- -/100

Read more